Vaccine manufacturing services for infectious diseases
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N98026D00085
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases Pre-Solicitation · 75N93024R00004 · Posted Nov 24, 2023
- Last date to order 1% complete
- IDV ceiling
- $48,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 30 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a multiple-award Indefinite Delivery Contract to Advanced Bioscience Laboratories, Inc. with a ceiling of $48 million on September 25, 2026. The contract supports development of vaccine and biologic candidates as medical countermeasures against infectious diseases, including product development plans, product construction and development, manufacture of clinical and non-clinical materials, and regulatory support services.
Work is performed in compliance with current Good Manufacturing Practice (cGMP) and applicable regulatory requirements. The period of performance extends through September 24, 2036.
NAICS code 325414 and PSC code R425 apply. Task order values are anticipated to range from $250,000 to over $5 million, with a total ordering period of seven years, extending to ten years for certain task areas.
The underlying solicitation, posted November 24, 2023, sought capability statements from manufacturers capable of supporting development of medical countermeasures across multiple infectious disease targets. Advanced Bioscience Laboratories, Inc. was one of multiple awardees selected to replace expiring incumbents under this vehicle structure.
Quick answers
Who was awarded contract 75N98026D00085?
75N98026D00085 was awarded to Advanced Bioscience Laboratories, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 25, 2026.
How much is contract 75N98026D00085 worth?
75N98026D00085's own ceiling is $48,000,000.
Which agency awarded contract 75N98026D00085?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026D00085, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Who can order from contract 75N98026D00085?
75N98026D00085 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N98026D00085 competed?
The extent of competition for 75N98026D00085 was full and open competition. The government received 30 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV